336 related articles for article (PubMed ID: 22987045)
1. The meta-analysis of the association of PPARG P12A, C161T polymorphism and coronary heart disease.
Ding S; Liu L; Zhuge QC; Yu Z; Zhang X; Xie J; Hong W; Wang S; Yang Y; Chen B
Wien Klin Wochenschr; 2012 Oct; 124(19-20):671-7. PubMed ID: 22987045
[TBL] [Abstract][Full Text] [Related]
2. Association between peroxisome proliferator-activated receptor-alpha, delta, and gamma polymorphisms and risk of coronary heart disease: A case-control study and meta-analysis.
Qian Y; Li P; Zhang J; Shi Y; Chen K; Yang J; Wu Y; Ye X
Medicine (Baltimore); 2016 Aug; 95(32):e4299. PubMed ID: 27512842
[TBL] [Abstract][Full Text] [Related]
3. PPARgamma polymorphisms and cancer risk: a meta-analysis involving 32,138 subjects.
Xu W; Li Y; Wang X; Chen B; Liu S; Wang Y; Zhao W; Wu J
Oncol Rep; 2010 Aug; 24(2):579-85. PubMed ID: 20596649
[TBL] [Abstract][Full Text] [Related]
4. Effects of the PPARG P12A and C161T gene variants on serum lipids in coronary heart disease patients with and without Type 2 diabetes.
Yilmaz-Aydogan H; Kurnaz O; Kurt O; Akadam-Teker B; Kucukhuseyin O; Tekeli A; Isbir T
Mol Cell Biochem; 2011 Dec; 358(1-2):355-63. PubMed ID: 21833536
[TBL] [Abstract][Full Text] [Related]
5. Associations between PPARG polymorphisms and the risk of essential hypertension.
Cai G; Zhang X; Weng W; Shi G; Xue S; Zhang B
PLoS One; 2017; 12(7):e0181644. PubMed ID: 28727849
[TBL] [Abstract][Full Text] [Related]
6. PPARG gene C161T CT/TT associated with lower blood lipid levels and ischemic stroke from large-artery atherosclerosis in a Han population in Guangdong.
Wei WM; Wu XY; Li ST; Shen Q
Neurol Res; 2016 Jul; 38(7):620-4. PubMed ID: 27264718
[TBL] [Abstract][Full Text] [Related]
7. Association between Peroxisome Proliferator-activated Receptor Gamma Gene Polymorphisms and Atherosclerotic Diseases: A Meta-analysis of Case-control Studies.
Wang P; Wang Q; Yin Y; Yang Z; Li W; Liang D; Zhou P
J Atheroscler Thromb; 2015; 22(9):912-25. PubMed ID: 25832497
[TBL] [Abstract][Full Text] [Related]
8. The C161T polymorphism in the peroxisome proliferator-activated receptor gamma gene (PPARγ) is associated with risk of coronary artery disease: a meta-analysis.
Wu Z; Lou Y; Jin W; Liu Y; Lu L; Lu G
Mol Biol Rep; 2013 Apr; 40(4):3101-12. PubMed ID: 23266668
[TBL] [Abstract][Full Text] [Related]
9. The Role of PPAR-gamma C161T Polymorphism in Colorectal Cancer Susceptibility.
Kurnaz-Gomleksiz O; Torun BC; Isbir T; Bulut T; Sokucu N; Yilmaz-Aydogan H; Canbay E
In Vivo; 2022; 36(4):1911-1915. PubMed ID: 35738614
[TBL] [Abstract][Full Text] [Related]
10. The effect of PPARG gene polymorphisms on the risk of coronary heart disease: a meta-analysis.
Xu W; Xu J; Sun B; Chen H; Wang Y; Huang F; Xi P; Jiang J
Mol Biol Rep; 2013 Feb; 40(2):875-84. PubMed ID: 23065280
[TBL] [Abstract][Full Text] [Related]
11. Distribution of peroxisome proliferator-activated receptor-gamma polymorphisms in Chinese and Dutch patients with inflammatory bowel disease.
Shrestha UK; Karimi O; Crusius JB; Zhou F; Wang Z; Chen Z; van Bodegraven AA; Xiao J; Morré SA; Wang H; Li J; Xia B
Inflamm Bowel Dis; 2010 Feb; 16(2):312-9. PubMed ID: 19714744
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor gamma-2 P12A polymorphism and risk of acute myocardial infarction, coronary heart disease and ischemic stroke: a case-cohort study and meta-analyses.
Zafarmand MH; van der Schouw YT; Grobbee DE; de Leeuw PW; Bots ML
Vasc Health Risk Manag; 2008; 4(2):427-36. PubMed ID: 18561518
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor-gamma gene polymorphism and risk of cardiovascular disease in patients with diabetic nephropathy.
Szeto CC; Chow KM; Poon PY; Kwan BC; Li PK
Am J Nephrol; 2008; 28(5):715-22. PubMed ID: 18417957
[TBL] [Abstract][Full Text] [Related]
14. Associations of Leptin Receptor and Peroxisome Proliferator-Activated Receptor Gamma Polymorphisms with Polycystic Ovary Syndrome: A Meta-Analysis.
Liang J; Lan J; Li M; Wang F
Ann Nutr Metab; 2019; 75(1):1-8. PubMed ID: 31412346
[TBL] [Abstract][Full Text] [Related]
15. Quantitative assessment of the influence of PPARG P12A polymorphism on gestational diabetes mellitus risk.
Wang C; Li X; Huang Z; Qian J
Mol Biol Rep; 2013 Feb; 40(2):811-7. PubMed ID: 23054024
[TBL] [Abstract][Full Text] [Related]
16. Analyses of association between PPAR gamma and EPHX1 polymorphisms and susceptibility to COPD in a Hungarian cohort, a case-control study.
Penyige A; Poliska S; Csanky E; Scholtz B; Dezso B; Schmelczer I; Kilty I; Takacs L; Nagy L
BMC Med Genet; 2010 Nov; 11():152. PubMed ID: 21044285
[TBL] [Abstract][Full Text] [Related]
17. PPARγ Pro12Ala and C161T polymorphisms in patients with acne vulgaris: Contribution to lipid and lipoprotein profile.
Saeidi S; Chamaie-Nejad F; Ebrahimi A; Najafi F; Rahimi Z; Vaisi-Raygani A; Shakiba E; Rahimi Z
Adv Med Sci; 2018 Mar; 63(1):147-151. PubMed ID: 29120856
[TBL] [Abstract][Full Text] [Related]
18. Association of the variants in the PPARG gene and serum lipid levels: a meta-analysis of 74 studies.
Li Q; Chen R; Bie L; Zhao D; Huang C; Hong J
J Cell Mol Med; 2015 Jan; 19(1):198-209. PubMed ID: 25265984
[TBL] [Abstract][Full Text] [Related]
19. PPARG (Pro12Ala) genetic variant and risk of T2DM: a systematic review and meta-analysis.
Sarhangi N; Sharifi F; Hashemian L; Hassani Doabsari M; Heshmatzad K; Rahbaran M; Jamaldini SH; Aghaei Meybodi HR; Hasanzad M
Sci Rep; 2020 Jul; 10(1):12764. PubMed ID: 32728045
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of association between the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ2 gene and diabetic retinopathy in Caucasians and Asians.
Ma J; Li Y; Zhou F; Xu X; Guo G; Qu Y
Mol Vis; 2012; 18():2352-60. PubMed ID: 22993484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
